Geron Corporation (GERN) — Stock Score Summary

Geron Corporation (GERN) has a MoatMap StockRank of 37/100 based on Quality (36/100), Value (41/100), and Momentum (47/100) factor scores. The current signal is HOLD. A late-stage biotech company with no current earnings or high ROIC, representing a binary regulatory/commercial bet rather than a quality compounder. It fails the Buffett and Smith quality filters.

Geron Corporation is a biopharmaceutical company focused on the development of novel therapeutics for hematologic malignancies. Its lead product candidate, imetelstat, targets telomerase, a unique mechanism of action for specific blood cancers. Geron operates in a high-risk, high-reward niche, aiming to address significant unmet medical needs in oncology.

Key Financial Metrics

Price$1.12
Market Cap$802M
P/E (Forward)18.62
Price/Book3.39
Return on Equity-27.1%
Return on Invested Capital-11.1%
Debt/Equity53.28
Gross Margin61.0%
Operating Margin-0.5%
Revenue Growth30.9%
Free Cash Flow$-92M

Geron Corporation operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Geron Corporation’s (GERN) StockRank?
MoatMap’s StockRank for Geron Corporation (GERN) is 37/100, with a Hold signal. It is a composite of Quality (36), Value (41), and Momentum (47) factor ranks across MoatMap’s 19,000+ stock universe.
Does Geron Corporation have an economic moat?
Geron Corporation (GERN) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Geron Corporation a buy, hold, or sell?
MoatMap’s current signal for Geron Corporation (GERN) is Hold, based on a StockRank of 37/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Geron Corporation in?
Geron Corporation (GERN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksGERN deep dive reportAI ChampionsHow we score stocksSense-check another stock